ABBOTT LABORATORIES news, videos and press releases - Page 5
For more news please use our advanced search feature.
ABBOTT LABORATORIES - More news...
ABBOTT LABORATORIES - More news...
- Gov. Abbott claps back at Biden admin: 'Flat out lie or total ignorance'
- This is a US problem: Gov. Greg Abbott
- Daily Podcast: Diane Abbott, antisemitism and a ‘hierarchy of racism’ in the UK
- Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
- Will Diane Abbott be reinstated to the Labour party?
- Diane Abbott has Labour whip suspended after remarks suggesting Jews do not face racism
- Abbott Laboratories - Form 8.3 - Allergy Therapeutics PLC
- Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change
- Thinking about trading options or stock in Legend Biotech, Abbott Laboratories, Johnson & Johnson, Coca-Cola, or Tesla?
- Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
- Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries
- FDA Clears Reader for Abbott's FreeStyle Libre® 3 System
- Abbott Hosts Conference Call for First-Quarter Earnings
- Don't Mess with Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get it Checked' in New Public Service Announcement
- Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion
- U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems
- Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device
- New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation
- ABBOTT LABORATORIES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Abbott Laboratories - ABT
- Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices
- Texas Gov. Abbott holds press conference on securing the border in 'Biden's absence'
- Live: Texas Gov. Abbott holds press conference on securing the border in 'Biden's absence'
- Abbott Declares 397th Consecutive Quarterly Dividend
- Biden’s border policies are ‘unequivocally’ against the law: Gov. Abbott
- Greg Abbott: Biden's new border policy will attract more illegal immigrants
- FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
- Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook
- ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis
- Biden or Abbott: Who’s handling the border crisis better? | Americans Weigh In